New pill tested for stubborn eczema that other treatments Can't control
Disease control
Completed
This early-stage study tested the safety and initial effectiveness of an oral medication called soquelitinib for adults with moderate-to-severe atopic dermatitis (eczema) who haven't responded well to other treatments. Researchers gave different doses to 82 participants, comparin…
Phase: PHASE1 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC